Mometason Paten

Mometason Paten. By intranasal administration For Child 3–11 years 50 micrograms daily dose to be sprayed into each nostril For Child 12–17 years 100 micrograms daily increased if necessary up to 200 micrograms daily dose to be sprayed into each nostril reduced to 50 micrograms daily dose to be reduced when control achieved dose to be sprayed into each nostril.

European Patent Office Prior art keywords composition water patient mometasone furoate age Prior art date 20070411 Legal status (The legal status is an assumption and is not a legal conclusion Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed) Withdrawn Application number Author Moshe Arkin Amira Zeevi Stephen Cherkez Eilon Asculai Rina Uzan Bella BraghinskiCited by Publish Year 2008.

MOMETASONE FUROATE Drug BNF content published by NICE

US6127353A Mometasone furoate monohydrate process for making same and pharmaceutical compositions Google Patents Author PuiHo Yuen Charles Eckhart Teresa Etlinger Nancy LevineCited by Publish Year 1991.

Package leaflet: Information for the patient Mometasone

European Patent Office Prior art keywords mometasone furoate ointment salicylic acid psoriasis hyperkeratotic Prior art date 19931221 Legal status (The legal status is an assumption and is not a legal conclusion Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed) Expired Lifetime Author Imtiaz A Chaudry Edwin A Peets Joel A Sequeira Daniel J Tanner Eugene L TaylorCited by Publish Year 1994.

US6127353A Mometasone furoate monohydrate Google Patents

Mometasone furoate 01%w/w Ointment (mometasone furoate) Read all of this leaflet carefully before you start using this medicine because it contains important information for you • Keep this leaflet You may need to read it again • If you have any further questions ask your doctor or pharmacist.